PAR - Par Drugs And Chemicals

Par Drugs And Chemicals

PAR · Pharma > Pharmaceuticals & Drugs · Chairman: Falgun Vallabhbhai Savani · MD: Falgun Vallabhbhai Savani · Listing date: May 16, 2019 · Employees: 92 · Bhavnagar · http://pardrugs.com

Stock Price vs Company Growth

4.8%

4.9%

13.4%

20.7%

56.0%

6.1%

all

19.9%

🤔 How to analyze this graph?

Last Traded Price

₹ 82.5 4.8%

82.5

106

Company Overview

Sales

106 Cr

Growth: -3.6%

Profit after Tax

13.9 Cr

Growth: 43.5%

Micro Cap

102 Cr

P/E: 7.3x

Industry P/E: 26.4x

Fundamentals

Sales (Cr)	₹ 106
Growth	-3.6%
EBITDA	17.0%
P/S	1.0x
Dividend	0.0%
P/E	7.3x
Book Value	₹ 90.4
PEG Ratio	-2.1x
ROE	13.3%
P/B	1.0x

Shareholding Pattern

Institutions

Sunita Ben Paragbhai Shah

1.92 %

Parag Jayantibhai Shah

1.14 %

Promoters

Jignesh Vallabhbhai Savani

21.78 %

Falgun Vallabhbhai Savani

21.5 %

Vallabhbhai J Savani

19.46 %

Ghanshayambhai B Savani

6.41 %

Saritaben Vallabhbhai Savani

1.8 %

Others

Increase Decrease No change

Company Profile Detailed

:PDCL is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for the domestic market as well as for exports to international markets. It currently produce various range of Antacid Molecules which are available in the market and are in great demand.Key Events and Milestones:1999: Incorporated as a Private Limited Company with the name ‘Par Drugs and Chemicals Private Limited’.1999: Acquisition of the ongoing business of the M/s. Par In Organic.

Investors (5)

econo.tr...

alpha.le...

coding